{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:06:52Z","timestamp":1770509212138,"version":"3.49.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T00:00:00Z","timestamp":1467158400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia (PT)","award":["SFRH\/BD\/89879\/2012"],"award-info":[{"award-number":["SFRH\/BD\/89879\/2012"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia (PT)","award":["SAESCTN-PIIC&DT\/1\/2011-Norte-07-0124-FEDER-000066"],"award-info":[{"award-number":["SAESCTN-PIIC&DT\/1\/2011-Norte-07-0124-FEDER-000066"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia (PT)","award":["SAESCTN-PIIC&DT\/1\/2011-Norte-07-0124-FEDER-000067"],"award-info":[{"award-number":["SAESCTN-PIIC&DT\/1\/2011-Norte-07-0124-FEDER-000067"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia (PT)","award":["007265-UID\/QUI\/50006\/2013"],"award-info":[{"award-number":["007265-UID\/QUI\/50006\/2013"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia (PT)","award":["Pest-C\/EQB\/LA0006\/2013"],"award-info":[{"award-number":["Pest-C\/EQB\/LA0006\/2013"]}]},{"name":"ICETA - Instituto de Ci\u00eancias e Tecnologias Agr\u00e1rias e Agro-Alimentares da Universidade do Porto","award":["UID\/MULTI\/01378\/2013"],"award-info":[{"award-number":["UID\/MULTI\/01378\/2013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s00204-016-1777-9","type":"journal-article","created":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T16:11:34Z","timestamp":1467216694000},"page":"1413-1430","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["In vitro hepatotoxicity of \u2018Legal X\u2019: the combination of 1-benzylpiperazine (BZP) and 1-(m-trifluoromethylphenyl)piperazine (TFMPP) triggers oxidative stress, mitochondrial impairment and apoptosis"],"prefix":"10.1007","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7331-9157","authenticated-orcid":false,"given":"Diana","family":"Dias da Silva","sequence":"first","affiliation":[]},{"given":"Maria Jo\u00e3o","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Patr\u00edcia","family":"Moreira","sequence":"additional","affiliation":[]},{"given":"Maria Jo\u00e3o","family":"Martins","sequence":"additional","affiliation":[]},{"given":"Maria Jo\u00e3o","family":"Valente","sequence":"additional","affiliation":[]},{"given":"F\u00e9lix","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"Maria de Lourdes","family":"Bastos","sequence":"additional","affiliation":[]},{"given":"Helena","family":"Carmo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,6,29]]},"reference":[{"issue":"1\u20133","key":"1777_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.forsciint.2009.01.015","volume":"186","author":"U Antia","year":"2009","unstructured":"Antia U, Lee HS, Kydd RR, Tingle MD, Russell BR (2009a) Pharmacokinetics of \u2018party pill\u2019 drug N-benzylpiperazine (BZP) in healthy human participants. Forensic Sci Int 186(1\u20133):63\u201367. doi: 10.1016\/j.forsciint.2009.01.015","journal-title":"Forensic Sci Int"},{"issue":"1303","key":"1777_CR2","first-page":"29","volume":"122","author":"U Antia","year":"2009","unstructured":"Antia U, Tingle MD, Russell BR (2009b) In vivo interactions between BZP and TFMPP (party pill drugs). N Z Med J 122(1303):29\u201338","journal-title":"N Z Med J"},{"issue":"7","key":"1777_CR3","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1211\/jpp\/61.07.0006","volume":"61","author":"U Antia","year":"2009","unstructured":"Antia U, Tingle MD, Russell BR (2009c) Metabolic interactions with piperazine-based \u2018party pill\u2019 drugs. J Pharm Pharmacol 61(7):877\u2013882. doi: 10.1211\/jpp\/61.07.0006","journal-title":"J Pharm Pharmacol"},{"issue":"5","key":"1777_CR4","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1111\/j.1556-4029.2010.01457.x","volume":"55","author":"U Antia","year":"2010","unstructured":"Antia U, Tingle MD, Russell BR (2010) Validation of an LC-MS method for the detection and quantification of BZP and TFMPP and their hydroxylated metabolites in human plasma and its application to the pharmacokinetic study of TFMPP in humans. J Forensic Sci 55(5):1311\u20131318. doi: 10.1111\/j.1556-4029.2010.01457.x","journal-title":"J Forensic Sci"},{"issue":"5","key":"1777_CR5","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00204-014-1278-7","volume":"89","author":"AM Araujo","year":"2015","unstructured":"Araujo AM, Valente MJ, Carvalho M et al (2015) Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of \u2018legal high\u2019 packages containing synthetic cathinones. Arch Toxicol 89(5):757\u2013771. doi: 10.1007\/s00204-014-1278-7","journal-title":"Arch Toxicol"},{"issue":"3","key":"1777_CR6","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.drugalcdep.2011.10.007","volume":"122","author":"MD Arbo","year":"2012","unstructured":"Arbo MD, Bastos ML, Carmo HF (2012) Piperazine compounds as drugs of abuse. Drug Alcohol Depend 122(3):174\u2013185. doi: 10.1016\/j.drugalcdep.2011.10.007","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"1777_CR7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.toxlet.2014.06.031","volume":"229","author":"MD Arbo","year":"2014","unstructured":"Arbo MD, Silva R, Barbosa DJ et al (2014) Piperazine designer drugs induce toxicity in cardiomyoblast h9c2 cells through mitochondrial impairment. Toxicol Lett 229(1):178\u2013189. doi: 10.1016\/j.toxlet.2014.06.031","journal-title":"Toxicol Lett"},{"issue":"1","key":"1777_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/jat.3153","volume":"36","author":"MD Arbo","year":"2016","unstructured":"Arbo MD, Silva R, Barbosa DJ et al (2016) In vitro neurotoxicity evaluation of piperazine designer drugs in differentiated human neuroblastoma SH-SY5Y cells. J Appl Toxicol JAT 36(1):121\u2013130. doi: 10.1002\/jat.3153","journal-title":"J Appl Toxicol JAT"},{"issue":"4","key":"1777_CR9","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1440-1665.2004.02137.x","volume":"12","author":"H Austin","year":"2004","unstructured":"Austin H, Monasterio E (2004) Acute psychosis following ingestion of \u2018Rapture\u2019. Australas Psychiatry 12(4):406\u2013408. doi: 10.1111\/j.1440-1665.2004.02137.x","journal-title":"Australas Psychiatry"},{"issue":"3","key":"1777_CR10","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/sj.npp.1300585","volume":"30","author":"MH Baumann","year":"2005","unstructured":"Baumann MH, Clark RD, Budzynski AG, Partilla JS, Blough BE, Rothman RB (2005) N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or \u2018Ecstasy\u2019). Neuropsychopharmacology 30(3):550\u2013560. doi: 10.1038\/sj.npp.1300585","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"1777_CR11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0031-6997(25)00026-2","volume":"41","author":"MC Berenbaum","year":"1989","unstructured":"Berenbaum MC (1989) What is synergy? Pharmacol Rev 41(2):93\u2013141","journal-title":"Pharmacol Rev"},{"key":"1777_CR12","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","volume":"26","author":"CI Bliss","year":"1939","unstructured":"Bliss CI (1939) The toxicity of poisons applied jointly. Ann Appl Biol 26:585\u2013615","journal-title":"Ann Appl Biol"},{"issue":"5","key":"1777_CR13","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2174\/138920110791591535","volume":"11","author":"M Carvalho","year":"2010","unstructured":"Carvalho M, Pontes H, Remiao F, Bastos ML, Carvalho F (2010) Mechanisms underlying the hepatotoxic effects of ecstasy. Curr Pharm Biotechnol 11(5):476\u2013495","journal-title":"Curr Pharm Biotechnol"},{"key":"1777_CR14","unstructured":"Chou K (2008) Distribution of BZP and TFMPP. Masters thesis, University of Auckland"},{"issue":"7351","key":"1777_CR15","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/474253a","volume":"474","author":"M Cole","year":"2011","unstructured":"Cole M (2011) Poison in party pills is too much to swallow. Nature 474(7351):253. doi: 10.1038\/474253a","journal-title":"Nature"},{"issue":"7","key":"1777_CR18","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/qjmed\/hcq056","volume":"103","author":"S Davies","year":"2010","unstructured":"Davies S, Wood DM, Smith G et al (2010) Purchasing \u2018legal highs\u2019 on the Internet\u2014is there consistency in what you get? QJM 103(7):489\u2013493. doi: 10.1093\/qjmed\/hcq056","journal-title":"QJM"},{"issue":"12","key":"1777_CR19","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1007\/s00204-013-1082-9","volume":"87","author":"D Dias da Silva","year":"2013","unstructured":"Dias da Silva D, Carmo H, Lynch A, Silva E (2013a) An insight into the hepatocellular death induced by amphetamines, individually and in combination: the involvement of necrosis and apoptosis. Arch Toxicol 87(12):2165\u20132185. doi: 10.1007\/s00204-013-1082-9","journal-title":"Arch Toxicol"},{"issue":"1","key":"1777_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00204-012-0929-9","volume":"87","author":"D Dias da Silva","year":"2013","unstructured":"Dias da Silva D, Carmo H, Silva E (2013b) The risky cocktail: what combination effects can we expect between ecstasy and other amphetamines? Arch Toxicol 87(1):111\u2013122. doi: 10.1007\/s00204-012-0929-9","journal-title":"Arch Toxicol"},{"issue":"6","key":"1777_CR21","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.tiv.2013.04.010","volume":"27","author":"D Dias da Silva","year":"2013","unstructured":"Dias da Silva D, Silva E, Carmo H (2013c) Cytotoxic effects of amphetamine mixtures in primary hepatocytes are severely aggravated under hyperthermic conditions. Toxicol In Vitro 27(6):1670\u20131678. doi: 10.1016\/j.tiv.2013.04.010","journal-title":"Toxicol In Vitro"},{"issue":"6","key":"1777_CR16","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/jat.2889","volume":"34","author":"D Dias da Silva","year":"2014","unstructured":"Dias\u00a0da Silva D, Silva E, Carmo H (2014a) Combination effects of amphetamines under hyperthermia\u2014the role played by oxidative stress. J Appl Toxicol JAT 34(6):637\u2013650. doi: 10.1002\/jat.2889","journal-title":"J Appl Toxicol JAT"},{"issue":"6","key":"1777_CR17","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/jat.2885","volume":"34","author":"D Dias\u00a0da Silva","year":"2014","unstructured":"Dias\u00a0da Silva D, Silva E, Carvalho F, Carmo H (2014b) Mixtures of 3,4-methylenedioxymethamphetamine (ecstasy) and its major human metabolites act additively to induce significant toxicity to liver cells when combined at low, non-cytotoxic concentrations. J Appl Toxicol JAT 34(6):618\u2013627. doi: 10.1002\/jat.2885","journal-title":"J Appl Toxicol JAT"},{"issue":"5","key":"1777_CR22","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.tiv.2015.04.001","volume":"29","author":"D Dias da Silva","year":"2015","unstructured":"Dias-da-Silva D, Arbo MD, Valente MJ, Bastos ML, Carmo H (2015) Hepatotoxicity of piperazine designer drugs: comparison of different in vitro models. Toxicol In Vitro 29(5):987\u2013996. doi: 10.1016\/j.tiv.2015.04.001","journal-title":"Toxicol In Vitro"},{"issue":"7","key":"1777_CR24","first-page":"64","volume":"42","author":"Drug Enforcement Administration","year":"2009","unstructured":"Drug Enforcement Administration (2009) Various tablets containing BZP and TFMPP in Washington, D.C. Microgram Bull 42(7):64","journal-title":"Microgram Bull"},{"key":"1777_CR25","unstructured":"Drugs-forums (2005) BZP\/TFMPP piperazine mix. https:\/\/drugs-forum.com\/forum\/showthread.php?t=6012"},{"issue":"7\u20138","key":"1777_CR26","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/dta.307","volume":"3","author":"S Elliott","year":"2011","unstructured":"Elliott S (2011) Current awareness of piperazines: pharmacology and toxicology. Drug Test Anal 3(7\u20138):430\u2013438. doi: 10.1002\/dta.307","journal-title":"Drug Test Anal"},{"issue":"2","key":"1777_CR27","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/jat\/32.2.172","volume":"32","author":"S Elliott","year":"2008","unstructured":"Elliott S, Smith C (2008) Investigation of the first deaths in the United Kingdom involving the detection and quantitation of the piperazines BZP and 3-TFMPP. J Anal Toxicol 32(2):172\u2013177","journal-title":"J Anal Toxicol"},{"key":"1777_CR28","unstructured":"Erowid (2003) Erowid piperazine vault: trifluoromethylphenylpiperazine (TFMPP)\u2014an entheogenic entactogen. http:\/\/www.erowid.org\/chemicals\/tfmpp\/tfmpp_article1.shtml . Accessed 29 Jan 2016"},{"key":"1777_CR29","unstructured":"Erowid (2004) Erowid experience vaults: piperazine reports. http:\/\/www.erowid.org\/chemicals\/piperazines . Accessed 28 Mar 2016"},{"key":"1777_CR30","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2015) New psychoactive substances in Europe. An update from the EU Early Warning System (March 2015). Publications Office of the European Union, Luxembourg. http:\/\/www.emcdda.europa.eu\/publications\/2015\/newpsychoactive-substances"},{"issue":"2","key":"1777_CR31","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.drugalcdep.2004.07.014","volume":"77","author":"WE Fantegrossi","year":"2005","unstructured":"Fantegrossi WE, Winger G, Woods JH, Woolverton WL, Coop A (2005) Reinforcing and discriminative stimulus effects of 1-benzylpiperazine and trifluoromethylphenylpiperazine in rhesus monkeys. Drug Alcohol Depend 77(2):161\u2013168. doi: 10.1016\/j.drugalcdep.2004.07.014","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"1777_CR32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0166-445X(02)00133-9","volume":"63","author":"M Faust","year":"2003","unstructured":"Faust M, Altenburger R, Backhaus T et al (2003) Joint algal toxicity of 16 dissimilarly acting chemicals is predictable by the concept of independent action. Aquat Toxicol 63(1):43\u201363","journal-title":"Aquat Toxicol"},{"issue":"1249","key":"1777_CR33","first-page":"U2422","volume":"120","author":"P Gee","year":"2007","unstructured":"Gee P, Fountain J (2007) Party on? BZP party pills in New Zealand. N Z Med J 120(1249):U2422","journal-title":"N Z Med J"},{"issue":"9","key":"1777_CR34","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1080\/15563650802307602","volume":"46","author":"P Gee","year":"2008","unstructured":"Gee P, Gilbert M, Richardson S, Moore G, Paterson S, Graham P (2008) Toxicity from the recreational use of 1-benzylpiperazine. Clin Toxicol 46(9):802\u2013807. doi: 10.1080\/15563650802307602","journal-title":"Clin Toxicol"},{"issue":"2","key":"1777_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10565-011-9208-4","volume":"28","author":"HH Gerets","year":"2012","unstructured":"Gerets HH, Tilmant K, Gerin B et al (2012) Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biol Toxicol 28(2):69\u201387. doi: 10.1007\/s10565-011-9208-4","journal-title":"Cell Biol Toxicol"},{"issue":"Suppl 1","key":"1777_CR36","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1289\/ehp.9357","volume":"115","author":"A Kortenkamp","year":"2007","unstructured":"Kortenkamp A (2007) Ten years of mixing cocktails: a review of combination effects of endocrine-disrupting chemicals. Environ Health Perspect 115(Suppl 1):98\u2013105. doi: 10.1289\/ehp.9357","journal-title":"Environ Health Perspect"},{"issue":"5","key":"1777_CR37","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0940-2993(11)80244-7","volume":"44","author":"M Kretzschmar","year":"1992","unstructured":"Kretzschmar M, Pfeifer U, Machnik G, Klinger W (1992) Glutathione homeostasis and turnover in the totally hepatectomized rat: evidence for a high glutathione export capacity of extrahepatic tissues. Exp Toxicol Pathol 44(5):273\u2013281. doi: 10.1016\/S0940-2993(11)80244-7","journal-title":"Exp Toxicol Pathol"},{"issue":"3","key":"1777_CR38","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00213-009-1669-2","volume":"207","author":"JC Lin","year":"2009","unstructured":"Lin JC, Bangs N, Lee H, Kydd RR, Russell BR (2009) Determining the subjective and physiological effects of BZP on human females. Psychopharmacology 207(3):439\u2013446. doi: 10.1007\/s00213-009-1669-2","journal-title":"Psychopharmacology"},{"issue":"9","key":"1777_CR39","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/dta.285","volume":"3","author":"JC Lin","year":"2011","unstructured":"Lin JC, Jan RK, Kydd RR, Russell BR (2011) Subjective effects in humans following administration of party pill drugs BZP and TFMPP alone and in combination. Drug Test Anal 3(9):582\u2013585. doi: 10.1002\/dta.285","journal-title":"Drug Test Anal"},{"key":"1777_CR40","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF01952257","volume":"114","author":"S Loewe","year":"1926","unstructured":"Loewe S, Muchnik H (1926) Effect of combinations: mathematical basis of the problem. Arch Exp Pathol Pharmakol 114:313\u2013326","journal-title":"Arch Exp Pathol Pharmakol"},{"key":"1777_CR41","unstructured":"Luft B, Dessauer P (2013) Emerging psychoactive substances\u2014spotlight on \u2018legal-highs\u2019. In: Graylands hospital drug bulletin, vol 20. North Metropolitan Health Service\u2014Mental Health"},{"key":"1777_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-016-9604-x","author":"K Persona","year":"2016","unstructured":"Persona K, Polus A, Goralska J, Gruca A, Dembinska-Kiec A, Piekoszewski W (2016) an in vitro study of the neurotoxic effects of N-benzylpiperazine: a designer drug of abuse. Neurotox Res. doi: 10.1007\/s12640-016-9604-x","journal-title":"Neurotox Res"},{"issue":"3","key":"1777_CR43","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2174\/1389200054021825","volume":"6","author":"RF Staack","year":"2005","unstructured":"Staack RF, Maurer HH (2005) Metabolism of designer drugs of abuse. Curr Drug Metab 6(3):259\u2013274","journal-title":"Curr Drug Metab"},{"issue":"1","key":"1777_CR44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1570-0232(01)00619-5","volume":"773","author":"RF Staack","year":"2002","unstructured":"Staack RF, Fritschi G, Maurer HH (2002) Studies on the metabolism and toxicological detection of the new designer drug N-benzylpiperazine in urine using gas chromatography-mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci 773(1):35\u201346","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"issue":"9","key":"1777_CR45","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1002\/jms.513","volume":"38","author":"RF Staack","year":"2003","unstructured":"Staack RF, Fritschi G, Maurer HH (2003) New designer drug 1-(3-trifluoromethylphenyl) piperazine (TFMPP): gas chromatography\/mass spectrometry and liquid chromatography\/mass spectrometry studies on its phase I and II metabolism and on its toxicological detection in rat urine. J Mass Spectrom JMS 38(9):971\u2013981. doi: 10.1002\/jms.513","journal-title":"J Mass Spectrom JMS"},{"issue":"2","key":"1777_CR46","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bcp.2003.08.029","volume":"67","author":"RF Staack","year":"2004","unstructured":"Staack RF, Paul LD, Springer D, Kraemer T, Maurer HH (2004) Cytochrome P450 dependent metabolism of the new designer drug 1-(3-trifluoromethylphenyl)piperazine (TFMPP). In vivo studies in Wistar and Dark Agouti rats as well as in vitro studies in human liver microsomes. Biochem Pharmacol 67(2):235\u2013244","journal-title":"Biochem Pharmacol"},{"key":"1777_CR47","volume-title":"The benzylpiperazine (BZP)\/trifluoromethylphenylpiperazine (TFMPP) and alcohol safety study. Report for the Ministry of Health","author":"I Thompson","year":"2008","unstructured":"Thompson I, Williams G, Aldington S et al (2008) The benzylpiperazine (BZP)\/trifluoromethylphenylpiperazine (TFMPP) and alcohol safety study. Report for the Ministry of Health. Medical Research Institute of New Zealand, Wellington"},{"issue":"3","key":"1777_CR48","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.tox.2013.06.009","volume":"311","author":"M Tu","year":"2013","unstructured":"Tu M, Sun S, Wang K et al (2013) Organic cation transporter 1 mediates the uptake of monocrotaline and plays an important role in its hepatotoxicity. Toxicology 311(3):225\u2013230. doi: 10.1016\/j.tox.2013.06.009","journal-title":"Toxicology"},{"key":"1777_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-015-1653-z","author":"MJ Valente","year":"2015","unstructured":"Valente MJ, Araujo AM, Silva R et al (2015) 3,4-Methylenedioxypyrovalerone (MDPV): in vitro mechanisms of hepatotoxicity under normothermic and hyperthermic conditions. Arch Toxicol. doi: 10.1007\/s00204-015-1653-z","journal-title":"Arch Toxicol"},{"key":"1777_CR50","unstructured":"Vaughan BR, Gautam L (2011) An investigation into the cellular cytotoxicity of benzylpiperazine (BZP) and its derivatives. In: American Academy of Forensic Sciences (AAFS) 63rd Annual Meeting, Chicago, IL, 2011, vol 17"},{"issue":"4","key":"1777_CR51","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/BF03161209","volume":"4","author":"DM Wood","year":"2008","unstructured":"Wood DM, Button J, Lidder S, Ramsey J, Holt DW, Dargan PI (2008) Dissociative and sympathomimetic toxicity associated with recreational use of 1-(3-trifluoromethylphenyl) piperazine (TFMPP) and 1-benzylpiperzine (BZP). J Med Toxicol 4(4):254\u2013257","journal-title":"J Med Toxicol"},{"issue":"1376","key":"1777_CR52","first-page":"61","volume":"126","author":"SA Young","year":"2013","unstructured":"Young SA, Thrimawithana TR, Antia U et al (2013) Pharmaceutical quality of \u201cparty pills\u201d raises additional safety concerns in the use of illicit recreational drugs. N Z Med J 126(1376):61\u201370","journal-title":"N Z Med J"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-016-1777-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-016-1777-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-016-1777-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-016-1777-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T23:11:43Z","timestamp":1748992303000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-016-1777-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,29]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["1777"],"URL":"https:\/\/doi.org\/10.1007\/s00204-016-1777-9","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,29]]}}}